Artificial Intelligence

Shannon Cavallo's appointment as CFO signals a strategic shift, blending deep data analytics with a people-first ethos for the employee-owned firm.

The wealth tech leader unveils its InsightX platform and AI Innovation Lab, designed to make advanced analytics accessible to all financial professionals.

Computing power operator SAIHEAT is shifting its nuclear strategy from building reactors to selling design software, a bold move into a competitive market.

With new funding led by Telegraph Hill Partners, Kytopen is scaling its Flowfect® tech to make advanced cell therapies faster, cheaper, and more accessible.

With $23M from investors, Natter is scaling its AI platform that conducts thousands of 1:1 video chats to give leaders insights in hours, not weeks.

A new report reveals a major education gap in obesity care. Informed patients are now demanding options beyond blockbuster drugs like Wegovy and Zepbound.

Language services leader GLOBO hires a new CTO with deep AI expertise, signaling a major push to revolutionize communication for underserved populations.

A new partnership aims to tame AI for FinTech with a code-first approach, promising greater governance, agility, and cost savings over rigid SaaS platforms.

AIRNA has dosed the first patient with AIR-001, an RNA-editing drug that could treat both the lung and liver damage of a devastating genetic disease.

Backed by a $41.3M ARPA-H award, SonoNeu is pioneering sonogenetics, a non-invasive therapy using ultrasound to control cells and treat nerve pain.

A new Montreal-based collaboration aims to use advanced AI and a unique dataset to make drug development faster, smarter, and safer for patients.

Bit Digital reports a $147M paper loss on its ETH, pivots to riskier DeFi yields, and leans on its AI venture as a strategic counterbalance.

The firm adds veteran TD Cowen analyst Boris Peaker to deepen its research in oncology and genetic medicines, signaling a major bet on specialized insight.

New AI tools from Penguin Ai on Snowflake Marketplace aim to automate prior authorization and medical coding, targeting billions in administrative waste.

Avaí Bio and Austrianova are set to present new findings on a novel cell-based therapy designed to produce the 'longevity protein' Klotho.

In a major strategic move, Premier Research appoints Paul Spreen as CCO, signaling a bold push to capture the rebounding biotech market.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

The new algorithm aims to systematically filter out harmful interactions and reduce hidden trading costs in the complex world of off-exchange trading.

A new AI software that analyzes MRI scans has received a first-of-its-kind FDA classification, promising to help doctors differentiate complex brain disorders.

A new trial for advanced liver cancer tests visugromab, a drug aiming to overcome immunotherapy resistance and reverse debilitating cancer-related wasting.